Literature DB >> 23349428

Can infections cause Alzheimer's disease?

Francis Mawanda, Robert Wallace.   

Abstract

Late-onset Alzheimer's disease (AD) is the most prevalent cause of dementia among older adults, yet more than a century of research has not determined why this disease develops. One prevailing hypothesis is that late-onset AD is caused by infectious pathogens, an idea widely studied in both humans and experimental animal models. This review examines the infectious AD etiology hypothesis and summarizes existing evidence associating infectious agents with AD in humans. The various mechanisms through which different clinical and subclinical infections could cause or promote the progression of AD are considered, as is the concordance between putative infectious agents and the epidemiology of AD. We searched the PubMed, Web of Science, and EBSCO databases for research articles pertaining to infections and AD and systematically reviewed the evidence linking specific infectious pathogens to AD. The evidence compiled from the literature linking AD to an infectious cause is inconclusive, but the amount of evidence suggestive of an association is too substantial to ignore. Epidemiologic, clinical, and basic science studies that could improve on current understanding of the associations between AD and infections and possibly uncover ways to control this highly prevalent and debilitating disease are suggested.
© The Author 2013. Published by Oxford University Press on behalf of the Johns Hopkins Bloomberg School of Public Health. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  Alzheimer disease; bacteria; dementia; infection; neurodegenerative diseases; prions; sepsis; viruses

Mesh:

Year:  2013        PMID: 23349428      PMCID: PMC4707877          DOI: 10.1093/epirev/mxs007

Source DB:  PubMed          Journal:  Epidemiol Rev        ISSN: 0193-936X            Impact factor:   6.222


  243 in total

1.  PRNP Val129 homozygosity increases risk for early-onset Alzheimer's disease.

Authors:  Bart Dermaut; Esther A Croes; Rosa Rademakers; Marleen Van den Broeck; Marc Cruts; Albert Hofman; Cornelia M van Duijn; Christine Van Broeckhoven
Journal:  Ann Neurol       Date:  2003-03       Impact factor: 10.422

2.  Renal amyloidosis following tuberculosis.

Authors:  S J Tank; R S Chima; V Shah; S Malik; S Joshi; R H Mazumdar
Journal:  Indian J Pediatr       Date:  2000-09       Impact factor: 1.967

3.  Systemic immune aberrations in Alzheimer's disease patients.

Authors:  Konstantinos Bonotis; Eleni Krikki; Vasiliki Holeva; Christina Aggouridaki; Vasiliki Costa; Stavros Baloyannis
Journal:  J Neuroimmunol       Date:  2007-11-26       Impact factor: 3.478

4.  Detection of Helicobacter pylori in human carotid atherosclerotic plaques.

Authors:  S F Ameriso; E A Fridman; R C Leiguarda; G E Sevlever
Journal:  Stroke       Date:  2001-02       Impact factor: 7.914

5.  Productive herpes simplex virus in brain of elderly normal subjects and Alzheimer's disease patients.

Authors:  Matthew A Wozniak; Suzanne J Shipley; Marc Combrinck; Gordon K Wilcock; Ruth F Itzhaki
Journal:  J Med Virol       Date:  2005-02       Impact factor: 2.327

6.  Association between Helicobacter pylori infection and mild cognitive impairment.

Authors:  J Kountouras; M Tsolaki; M Boziki; E Gavalas; C Zavos; C Stergiopoulos; N Kapetanakis; D Chatzopoulos; I Venizelos
Journal:  Eur J Neurol       Date:  2007-09       Impact factor: 6.089

7.  Blood-brain barrier impairment in Alzheimer disease: stability and functional significance.

Authors:  G L Bowman; J A Kaye; M Moore; D Waichunas; N E Carlson; J F Quinn
Journal:  Neurology       Date:  2007-05-22       Impact factor: 9.910

8.  APOE genotype affects outcome in a murine model of sepsis: implications for a new treatment strategy.

Authors:  H Wang; D J Christensen; M P Vitek; P M Sullivan; D T Laskowitz
Journal:  Anaesth Intensive Care       Date:  2009-01       Impact factor: 1.669

9.  Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium.

Authors:  L A Farrer; L A Cupples; J L Haines; B Hyman; W A Kukull; R Mayeux; R H Myers; M A Pericak-Vance; N Risch; C M van Duijn
Journal:  JAMA       Date:  1997 Oct 22-29       Impact factor: 56.272

Review 10.  APP processing in Alzheimer's disease.

Authors:  Yun-wu Zhang; Robert Thompson; Han Zhang; Huaxi Xu
Journal:  Mol Brain       Date:  2011-01-07       Impact factor: 4.041

View more
  39 in total

1.  Editorial: epidemiologic reviews 2013-special issue on the epidemiology of aging.

Authors:  Robert B Wallace
Journal:  Epidemiol Rev       Date:  2013-02-04       Impact factor: 6.222

Review 2.  Gut Microbiota Disorder, Gut Epithelial and Blood-Brain Barrier Dysfunctions in Etiopathogenesis of Dementia: Molecular Mechanisms and Signaling Pathways.

Authors:  Menizibeya O Welcome
Journal:  Neuromolecular Med       Date:  2019-05-21       Impact factor: 3.843

3.  Genetic Association of HLA Gene Variants with MRI Brain Structure in Alzheimer's Disease.

Authors:  Zi-Xuan Wang; Yu Wan; Lin Tan; Jinyuan Liu; Hui-Fu Wang; Fu-Rong Sun; Meng-Shan Tan; Chen-Chen Tan; Teng Jiang; Lan Tan; Jin-Tai Yu
Journal:  Mol Neurobiol       Date:  2016-04-07       Impact factor: 5.590

4.  No Association Found Between Midlife Seropositivity for Infection and Subsequent Cognitive Decline: The Atherosclerosis Risk in Communities Neurocognitive Study (ARIC-NCS).

Authors:  Kristen M George; Aaron R Folsom; Faye L Norby; Pamela L Lutsey
Journal:  J Geriatr Psychiatry Neurol       Date:  2019-06-16       Impact factor: 2.680

5.  Aβ Plaques.

Authors:  Lary C Walker
Journal:  Free Neuropathol       Date:  2020-10-30

Review 6.  The Promises and Challenges of Erythropoietin for Treatment of Alzheimer's Disease.

Authors:  Jiahong Sun; Jan Michelle Martin; Victoria Vanderpoel; Rachita K Sumbria
Journal:  Neuromolecular Med       Date:  2019-01-17       Impact factor: 3.843

Review 7.  A Comprehensive Review on the Role of the Gut Microbiome in Human Neurological Disorders.

Authors:  Shokufeh Ghasemian Sorboni; Hanieh Shakeri Moghaddam; Reza Jafarzadeh-Esfehani; Saman Soleimanpour
Journal:  Clin Microbiol Rev       Date:  2022-01-05       Impact factor: 26.132

8.  Human antimicrobial peptide LL-37 contributes to Alzheimer's disease progression.

Authors:  Xue Chen; Suixin Deng; Wenchao Wang; Stefania Castiglione; Zilei Duan; Lei Luo; Francesca Cianci; Xiaoxue Zhang; Jianglei Xu; Hao Li; Jizong Zhao; Peter Muiruri Kamau; Zhiye Zhang; James Mwangi; Jiali Li; Yousheng Shu; Xintian Hu; Michele Mazzanti; Ren Lai
Journal:  Mol Psychiatry       Date:  2022-09-22       Impact factor: 13.437

9.  Clinical outcomes of COVID-19 infection among patients with Alzheimer's disease or mild cognitive impairment.

Authors:  Ying Wang; Mingfei Li; Lewis E Kazis; Weiming Xia
Journal:  Alzheimers Dement       Date:  2022-04-04       Impact factor: 16.655

Review 10.  Toxoplasma gondii: A possible etiologic agent for Alzheimer's disease.

Authors:  Tooran Nayeri; Shahabeddin Sarvi; Mehdi Sharif; Ahmad Daryani
Journal:  Heliyon       Date:  2021-06-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.